Compounding Pharmacy · Est. 2009 · Houston, TX · Both
Empower Pharmacy Review
Empower Pharmacy is a Houston-based compounder that runs a 503A pharmacy and Empower Pharma, an FDA-registered 503B outsourcing facility it describes as the nation's largest; a second Empower 503B site in East Windsor, New Jersey is also registered with FDA. Empower supplies compounded semaglutide and tirzepatide to many of the nation's largest telehealth brands and operates its 503B under cGMP requirements. FDA issued warning letters to both the 503B and the 503A in April 2025, and a September 2026 warning letter to the 503A said some of its compounded semaglutide and tirzepatide products appear to be essentially copies of FDA-approved drugs.
In its September 2026 warning letter to Empower's 503A pharmacy, FDA said the pharmacy's semaglutide/cyanocobalamin and tirzepatide/niacinamide products appear to be essentially copies of approved drugs, the question our compounded semaglutide status tracker follows. Because Empower runs both a 503A pharmacy and a 503B outsourcing facility in Houston, patients of a program such as Eden can ask which Empower site fills their order. Our news report on the letter goes through what FDA said about the two blends.
6 FDA, state or legal actions on record. Most recent: FDA warning letter (Sep 18, 2026) — see the full record below.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Regulatory Actions
Telehealth Providers Sourcing From This Pharmacy
These telehealth brands are reported to fulfill some or all compounded GLP-1 prescriptions through Empower Pharmacy. Sourcing arrangements can change over time.
Eden
Best for: compounded semaglutide or tirzepatide at one flat monthly price that doesn't rise with your dose
Editorial score · methodology
Lavender Sky Health
Best for: comparing compounded GLP-1 plans across 11 named pharmacies, paying per consult with no membership
Editorial score · methodology
Mochi Health
Best for: insurance help for brand-name GLP-1s, or self-pay compounded GLP-1 priced by dose
Editorial score · methodology
Hers
Best for: women who want brand-name GLP-1s only, including the Wegovy pill and Foundayo, with a Hers membership
Editorial score · methodology
Hims
Best for: people who want brand-name GLP-1 pills or pens through a big-name app with 24/7 messaging
Editorial score · methodology
Editorial score · methodology
Certifications & Compliance
All sterile compounding pharmacies in the United States are required to follow United States Pharmacopeia General Chapter <797> sterile compounding standards[4], with finished preparations evaluated against USP <71> sterility testing[5] and USP <85> bacterial endotoxin testing[6] as appropriate for the product type.
Drugs Produced
Compounding pharmacies' ability to produce semaglutide or tirzepatide depends on the FDA Drug Shortage List status for each reference product; compounding eligibility can change when a drug moves on or off the shortage list[7].
States Licensed (49)
External Reviews
Weight Loss Rankings Score Breakdown
Scores are independently researched. See our methodology for details.
High confidence · Pharmacy details last verified November 2026 · How we verify provider data
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- 503B outsourcing facility · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources & methodology (as of November 2026)
- 1.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 2.FDA — 503B Outsourcing Facility Registration and Requirements— U.S. Food & Drug Administration.
- 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 4.USP General Chapter <797> — Pharmaceutical Compounding: Sterile Preparations— United States Pharmacopeia.
- 5.USP General Chapter <71> — Sterility Tests— United States Pharmacopeia.
- 6.USP General Chapter <85> — Bacterial Endotoxins Test— United States Pharmacopeia.
- 7.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.